Vascular Access Catheters Industry to Reach USD 5.2 Billion by 2032 with a 5.7 % of CAGR, Steady Demand for Non-Antimicrobial Solutions

Vascular Access Catheters Industry
Vascular Access Catheters Industry

The global vascular access catheters market is poised for consistent growth, with its valuation expected to rise from USD 3.0 billion in 2022 to USD 5.2 billion by 2032, registering a compound annual growth rate (CAGR) of 5.7% during the forecast period. The non-antimicrobial segment has maintained a dominant position in the market, with a valuation of USD 2.2 billion in 2021, highlighting its widespread adoption in various medical settings.

Vascular access catheters play a critical role in delivering life-saving therapies, including medication administration, dialysis, and parenteral nutrition. The non-antimicrobial segment continues to lead due to its cost-effectiveness and suitability for short-term use, while the antimicrobial segment is gaining traction for its ability to mitigate catheter-related infections, particularly in high-risk patients.

The market growth is underpinned by the rising prevalence of chronic diseases such as cancer and kidney disorders, which necessitate long-term vascular access solutions. Additionally, technological advancements and a growing focus on patient safety are driving the development of innovative catheter designs with improved functionality and infection control.

A Detailed Full Report – https://www.futuremarketinsights.com/reports/vascular-access-catheters-market

Key Takeaways:

  • Market Growth: Valuation projected to grow from $3.0 billion in 2022 to $5.2 billion by 2032 at a CAGR of 5.7%.
  • Non-Antimicrobial Segment: Dominated the market with a valuation of $2.2 billion in 2021.
  • Driving Factors: Rising prevalence of chronic diseases and growing demand for cost-effective vascular access solutions.
  • Future Trends: Innovations in catheter design and increased adoption of antimicrobial catheters to enhance patient outcomes.

This sustained growth trajectory underscores the critical role of vascular access catheters in modern healthcare and their potential to improve treatment delivery and patient safety worldwide.

Growth Drivers

  1. Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular diseases necessitates the use of vascular access devices for long-term treatment and monitoring.
  2. Technological Advancements: Innovations in catheter design, including the development of antimicrobial coatings and improved insertion techniques, are enhancing the safety and effectiveness of vascular access procedures.
  3. Growing Geriatric Population: An aging population that requires frequent medical interventions is driving demand for vascular access devices, as older adults often have multiple health issues requiring ongoing treatment.
  4. Increased Surgical Procedures: The rise in surgical procedures and minimally invasive techniques is boosting the need for reliable vascular access solutions

Competitive landscape

Advancements in biocompatibility, flexibility, and the adoption of novel materials are shaping the demand of such efficient and quality products in the vascular access catheters market.

Players in the vascular access catheters market are looking forward to expand their market and create strong hold in consumer base from long-term vascular access catheters (VACs). Manufacturers have benefitted from the growing understanding of the diagnosis of VAC-related infections. Technological advancements especially concerning to designs and materials have enabled healthcare workers to overcome complex VAC infection and complications. These factors are the prospects of new technologies in the vascular access catheters market.

Key pharma players proactively working in the vascular access catheters market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, B Braun Melsungen AG and others.

  • In June, 2021, medK launched a needle-free solution for vascular access to reduce the risks of needle sticks injuries.
  • In October, 2020, Medtronic acquired Avenu Medical. The company Avenu Medical is focusing on the construction of minimally invasive endovascular arteriovenous fistulae for the treatment of end-stage renal disease patients undergoing dialysis.

Key Companies Profiled

AngioDynamics; C.R. Bard; Teleflex Incorporated; Kimal; B. Braun Melsungen AG; Vygon (UK) Ltd.; Fresenius Kabi AG; Becton; Dickinson and Company; Argon Medical Devices, Inc.; Boston Scientific Corporation; Cook Medical Incorporated; Medical Components, Inc.; Medtronic PLC.; Terumo Medical Corporation; NIPRO Medical Corporation; Angiodynamics; Edwards Lifesciences Corporation

Key Market Segments Covered in Vascular Access Catheters Industry Research

By Products:

  • Dialysis Catheters
    • Acute Hemodialysis Catheters
    • Chronic Hemodialysis Catheters
    • Peritoneal Dialysis Catheters
  • PICC Catheters
  • Implantable Port
  • CVC Catheters
    • Tunneled Catheters
    • Non-Tunneled Catheters

By Property:

  • Antimicrobial Catheters
  • Non-Antimicrobial Catheters

By Design:

  • Single Lumen
  • Double Lumen
  • Multiple Lumen

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Specialty Clinics and Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *